Acanthamoeba scleral abscess reoccurring after penetrating keratoplasty

BMJ Case Rep. 2021 Jun 21;14(6):e241864. doi: 10.1136/bcr-2021-241864.

Abstract

Two months following penetrating keratoplasty for Acanthamoeba keratitis, a 76-year-old man was referred due to inability to wean high-dose topical steroids. Despite a very healthy graft and minimal pain, a scleral abscess involving three clock hours of the superior conjunctiva was present. The patient underwent conjunctival and scleral excision of the area of apparent infection with adjuvant mitomycin C and double freeze-thaw cryotherapy treatment followed by amniotic membrane graft. Recurrence was confirmed with PCR. Following a multimonth regimen of oral voriconazole and topical polyhexamethylene biguanide, chlorhexidine and moxifloxacin, the patient was weaned from all anti-infectious agents. After cataract surgery and scleral lens fitting, the patient is now 20/20 in the affected eye. This case highlights the need for judicious use of immunosuppressive agents as well as the necessary vigilance to monitor for recurrence with Acanthamoeba infection. It also represents the first reported use of adjuvant mitomycin C and double freeze-thaw cryotherapy for treatment of Acanthamoeba scleral abscess.

Keywords: anterior chamber; infectious diseases; ophthalmology; pharmacology and therapeutics; surgery.

Publication types

  • Case Reports

MeSH terms

  • Abscess
  • Acanthamoeba Keratitis*
  • Acanthamoeba*
  • Aged
  • Humans
  • Keratoplasty, Penetrating
  • Male
  • Voriconazole

Substances

  • Voriconazole